Pharmacological activation of AMPK prevents Drp1-mediated mitochondrial fission and alleviates endoplasmic reticulum stress-associated endothelial dysfunction

J Mol Cell Cardiol. 2015 Sep:86:62-74. doi: 10.1016/j.yjmcc.2015.07.010. Epub 2015 Jul 18.

Abstract

Background and purpose: This study aims to investigate whether and how pharmacological activation of AMP-activated protein kinase (AMPK) improves endothelial function by suppressing mitochondrial ROS-associated endoplasmic reticulum stress (ER stress) in the endothelium. Experimental approach Palmitate stimulation induced mitochondrial fission and ER stress-associated endothelial dysfunction. The effects of AMPK activators salicylate and AICA riboside (AICAR) on mitochondrial ROS production, Drp1 phosphorylation, mitochondrial fission, ER stress, thioredoxin-interacting protein (TXNIP)/NLRP3 inflammasome activation, inflammation, cell apoptosis and endothelium-dependent vasodilation were observed. Key results "Silencing" of TXNIP by RNA interference inhibited NLRP3 inflammasome activation in response to ER stress, indicating that TXNIP was a key link between ER stress and NLRP3 inflammasome activation. AMPK activators salicylate and AICAR prevented ROS-induced mitochondrial fission by enhancing dynamin-related protein 1 (Drp1) phosphorylation (Ser 637) and thereby attenuated IRE-1α and PERK phosphorylation, but their actions were blocked by knockdown of AMPK. Salicylate and AICAR reduced TXNIP induction and inhibited NLRP3 inflammasome activation by reducing NLRP3 and caspase-1 expression, leading to a reduction in IL-1β secretion. As a result, salicylate and AICAR inhibited inflammation and reduced cell apoptosis. Meanwhile, salicylate and AICAR enhanced eNOS phosphorylation and restored the loss of endothelium-dependent vasodilation in the rat aorta. Immunohistochemistry staining showed that AMPK activation inhibited ER stress and NLRP3 inflammasome activation in the vascular endothelium.

Conclusion and implications: Pharmacological activation of AMPK regulated mitochondrial morphology and ameliorated endothelial dysfunction by suppression of mitochondrial ROS-associated ER stress and subsequent TXNIP/NLRP3 inflammasome activation. These findings suggested that regulation of Drp1 phosphorylation by AMPK activation contributed to suppression of ER stress and thus presented a potential therapeutic strategy for AMPK activation in the regulation of endothelium homeostasis.

Keywords: AMPK; Endoplasmic reticulum stress; Endothelial dysfunction; Mitochondrial fission; NLRP3 inflammasome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases / biosynthesis*
  • AMP-Activated Protein Kinases / genetics
  • Aminoimidazole Carboxamide / administration & dosage
  • Aminoimidazole Carboxamide / analogs & derivatives
  • Animals
  • Carrier Proteins / biosynthesis*
  • Carrier Proteins / genetics
  • Caspase 1 / biosynthesis
  • Cell Cycle Proteins
  • Dynamins / biosynthesis*
  • Dynamins / genetics
  • Endoplasmic Reticulum Stress / drug effects*
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / metabolism
  • Endothelium, Vascular / pathology
  • Gene Expression Regulation / drug effects
  • Humans
  • Inflammation / drug therapy
  • Inflammation / genetics*
  • Inflammation / pathology
  • Interleukin-1beta / metabolism
  • Mitochondrial Dynamics / drug effects
  • Rats
  • Ribonucleotides / administration & dosage
  • Salicylates / administration & dosage
  • Vasodilation / drug effects

Substances

  • Carrier Proteins
  • Cell Cycle Proteins
  • IL1B protein, rat
  • Interleukin-1beta
  • Ribonucleotides
  • Salicylates
  • TXNIP protein, rat
  • Aminoimidazole Carboxamide
  • AMP-Activated Protein Kinases
  • Prkaa1 protein, rat
  • Caspase 1
  • Dnm1l protein, rat
  • Dynamins
  • AICA ribonucleotide